Kythera Biopharamaceuticals
Download our corporate fact sheet
Careers  |  Contact Us
  • Home
  • About
  • Pipeline
  • Our Team
  • Investors
  • Newsroom
About
  • Our Story
  • Board of Directors
  • Company Advisors
  • Collaborative Partners
  • Values
Pipeline
  • Overview
  • ATX-101
Investors
  • Overview
  • Earnings Releases
  • Stock Information
  • Financial Information
  • Corporate Governance
  • Events & Presentations
  • Analyst Coverage
  • Investor FAQs
  • Contact Us
Newsroom
  • Press Releases
  • Media Coverage

Newsroom

  • Press Releases
    • Current
    • 2013 Archive
    • 2012 Archive
    • 2011 Archive
    • 2010 Archive
    • 2009 Archive
    • 2008 Archive
    • 2007 Archive
    • 2006 Archive
    • Media Coverage »

Kythera Newsroom

2007 Archive

December 20, 2007
KYTHERA Biopharmaceuticals Announces Discontinuation Of Actinic Keratosis Clinical Program

November 29, 2007
KYTHERA Biopharmaceuticals Appoints Amgen Veteran As Chief Financial Officer

November 14, 2007
KYTHERA Biopharmaceuticals Appoints Industry Veteran As Vice President, Regulatory Affairs

August 28, 2007
KYTHERA Biopharmaceuticals Initiates Phase II Study Of Its Adipolytic Agent For Reduction Of Submental Fat

June 5, 2007
KYTHERA Biopharmaceuticals To Participate In The Private Company Forum At The 28th Annual Goldman Sachs Global Healthcare Conference

April 24, 2007
KYTHERA Biopharmaceuticals Appoints Vice President, Product Development And Operations

April 24, 2007
KYTHERA Biopharmaceuticals Appoints New Chief Medical Officer

January 8, 2007
KYTHERA Biopharmaceuticals Signs Agreement For Access To Worldwide Rights For Topical Agent For The Treatment Of Actinic Keratos

View Pipeline »
Hide
Submental Fat Reduction »
Home | About | Pipeline | Our Team | Investors | Newsroom | Careers | Contact Us | Site Map
© 2013 Kythera Biopharmaceuticals, Inc. | Website by RBD